Με εβδομαδιαίες απώλειες άνω του 1% ολοκλήρωσαν τα περισσότερα ευρωπαϊκά χρηματιστήρια

Με αρνητικά πρόσημα ολοκλήρωσαν την τελευταία συνεδρίαση της εβδομάδας τα ευρωπαϊκά χρηματιστήρια, στον απόηχο της κινεζικής εταιρείας Evergrande της αίτησης προστασίας από τους επενδυτές στις ΗΠΑ, αλλά και από τα τελευταία στοιχεία για τον πληθωρισμό στην ευρωζώνη.

Στην Μεγάλη Βρετανία οι λιανικές πωλήσεις για τον μήνα Ιούλιο, υποχώρησαν 1,2% έναντι εκτιμήσεων για υποχώρηση 0,5%, και αύξησης 0,6% τον προηγούμενο μήνα, ενώ σε ετήσια βάση υποχώρησαν 3,2% έναντι εκτιμήσεων για υποχώρηση 2,1%, και υποχώρησης 1,6% το προηγούμενο έτος. Οι δομικές λιανικές πωλήσεις υποχώρησαν 1,4% έναντι εκτιμήσεων για υποχώρηση 0,7%, αύξησης 0,7% τον προηγούμενο μήνα, ενώ ετήσια βάση υποχώρησαν 3,4% έναντι εκτιμήσεων για υποχώρηση 2,2%, και υποχώρησης 1,6% το προηγούμενο έτος.

Στην ευρωζώνη ο Δείκτης Τιμών Καταναλωτή για τον μήνα Ιούλιο, υποχώρησε 0,1% (σύμφωνα με τις εκτιμήσεις των οικονομολόγων), και αύξησης 0,3% τον προηγούμενο μήνα, ενώ σε ετήσια βάση ενισχύθηκε 5,3% (σύμφωνα με τις εκτιμήσεις των οικονομολόγων), και αύξησης 5,5% το προηγούμενο έτος. Ο δομικός Δείκτης Τιμών Καταναλωτή για τον μήνα Ιούλιο, υποχώρησε 0,1% (σύμφωνα με τις εκτιμήσεις των οικονομολόγων), και αύξησης 0,4% τον προηγούμενο μήνα, ενώ ετήσια βάση αυξήθηκε 5,5% (σύμφωνα με τις εκτιμήσεις των οικονομολόγων), έναντι αύξησης 5,5% το προηγούμενο έτος.

Ο δείκτης Eurostoxx 600 έκλεισε στις 447,24 μονάδες με πτώση 0,88%.

Στην Φρανκφούρτη ο δείκτης DAX έκλεισε στις 15.575,35 μονάδες με πτώση 0,65%, παραμένοντας με σήμα strong sell, με την αντίσταση να βρίσκεται στις 16.488 μονάδες και την στήριξη στις 15.143 μονάδες.

Μεγαλύτερη άνοδος

Μεγαλύτερη πτώση

Στο Λονδίνο ο δείκτης FTSE 100 έκλεισε στις 7.264,41 μονάδες μe πτώση 0,63%, παραμένοντας με σήμα strong sell, με την αντίσταση να βρίσκεται στις 7.911 μονάδες και την στήριξη στις 6.972 μονάδες.

Μεγαλύτερη άνοδος

Μεγαλύτερη πτώση

Στο Παρίσι ο δείκτης CAC 40 έκλεισε στις 7.164,11 μονάδες με πτώση 0,38%, παραμένοντας με σήμα strong sell, με την αντίσταση να βρίσκεται στις 7.599 μονάδες και την στήριξη στις 6.931 μονάδες.

Μεγαλύτερη άνοδος

Μεγαλύτερη πτώση

Εταιρικά νέα

Novartis said the planned spinoff of its Sandoz unit is expected to occur in early October, ending an era for the Swiss pharmaceutical giant in which generic and prescription drugs businesses coexisted under the same roof.

Sandoz, which focuses on generic drugs and biosimilars, is expected to start trading as a standalone company on the SIX Swiss Exchange on or around Oct. 4, according to a listing prospectus published Friday. Sandoz will also have an American depositary receipt–or ADR–program in the U.S.

The listing of Sandoz would culminate a separation process that Novartis launched last year in a bid to sharpen its focus on innovative prescription medicines, following similar moves from industry peers in recent years.

Novartis said the separation will take place through a proposed distribution of Sandoz shares to its existing shareholders. Novartis shareholders will get one Sandoz share for every five Novartis shares held and one Sandoz ADR for every five Novartis ADRs, the company said.

The Sandoz spinoff remains subject to approval by Novartis’s shareholders. Novartis has scheduled an extraordinary general meeting for Sept. 15 to vote on the proposed distribution of Sandoz shares and a reduction in its own share capital in connection with the spinoff, it said. Novartis had previously said it expected the spinoff to happen early in the fourth quarter.

Sandoz generated pro forma total net sales of $9.12 billion and made a net profit of $677 million last year, according to its listing prospectus. Novartis said it intends to publish Sandoz’s financial statements for the first half of 2023 in early September. After the spinoff, Sandoz will remain dependent on Novartis for technical development and manufacturing for a significant time, according to its listing prospectus.

The companies will enter into development-collaboration and manufacturing-and-supply agreements, under which Novartis will support the development of certain Sandoz biosimilar assets for five years initially and provide commercial manufacture, supply of certain biosimilar products for the first ten years after the spinoff, Sandoz said in the prospectus.

Global Ports Holding posted a rise in revenue and core earnings for the first quarter of fiscal 2024 as its passenger numbers jumped and its occupancy levels returned to prepandemic levels. The cruise-port operator on Friday said that for the three months ended June 30 revenue was $53.4 million, compared with $45.7 million for the first quarter of fiscal 2023.

Adjusted earnings before interest, taxes, depreciation and amortization–a metric which strips out exceptional and other one-off items–rose to $28.6 million from $15.4 million in the year-prior period, the London-listed group said. Passengers in the period increased to 3.1 million from 1.7 million the year before, the company said.

Occupancy levels returned to prepandemic levels faster than expected, with an occupancy rate across its ports at 108% in June, it said. The recovery has resulted in the run rate for fiscal 2024 passenger volumes to currently stand ahead of its recently-issued guidance of exceeding 15 million passengers in the period, it said.

It added that the cruise industry outlook remains positive with passenger volumes expected to be 45% higher than prepandemic levels by the end of 2027. “Our call reservations point towards continued strong performance for the remainder of the fiscal year to March 2024,” said Chief Executive Mehmet Kutman.

Everyman Media Group said Friday that it has agreed a new three-year, 35 million pound ($44.6 million) line of credit with Barclays Bank and National Westminster Bank to ensure its financial structure is sound. The U.K. cinema operator said the line of credit is extendable by a further two years, subject to lenders’ consent. The new facility replaces an existing GBP25 million line of credit and a GBP15 million coronavirus large business interruption loan held with Barclays and Santander UK.

The U.K. competition regulator said it has decided not to refer the expected acquisition by U.K. water utility Severn Trent of waste-management company Andigestion to a Phase 2 investigation. The Competition and Markets Authority had said in late June that it was considering whether Severn Trent’s proposed acquisition of Andigestion would substantially lessen competition within any market or markets for goods or services in the country. Severn Trent said in February that it planned to acquire Andigestion through its Severn Trent Green Power subsidiary.

China Resources Beer’s first-half net profit jumped 22% as beer consumption recovered with the reopening of China’s economy. Net profit for six months ended June was 4.65 billion yuan (US$638.6 million), while revenue rose 14% from the previous year to CNY23.87 billion, the company said Friday. The liquor company attributed the rise in profits to increased sales as consumer sentiment improved. The average selling price of its beer increased 4.4% on year in first half, it said. Looking forward, China Resources Beer will “focus on expanding scale, improving quality, strengthening its foundation, optimizing pricing with modest adjustments, streamlining expenses and managing stores with more precision,” Executive Director Hou Xiaohai said.

Τα παραπάνω εκφράζουν προσωπικές απόψεις, και σε καμία περίπτωση δεν αποτελούν προτροπή για αγορά, πώληση ή διακράτηση οποιασδήποτε κινητής αξίας.